chronic myelogenous leukemia
March 11, 2017, 4:57 pm
In 2003, when Sam Fields was given two weeks to live, Gleevec wasn't known to help his condition. 14 years later, back from death's door, the athlete says without it, he simply 'wouldn't be here'
From the WebOctober 26, 2012, 6:32 pm
The treatment, to be marketed under the brand name Synribo, will be used to treat a type of blood and bone marrow cancer